title: Identification of a sodium-bicarbonate symport in human platelets.
abstract: Intracellular pH (pH(i)) was measured in human platelets using fluorescent probes. Basal pH(i) was higher in HC(O3-)- buffered solutions (7(7.33 +/- 0.01) than in nominally HCO3- free, Hepes buffered solutions (7.16 +/- 0.01, P < 0.05). Addition of EIPA caused to fall in Hepes, but did not inhibit the increase of pH(i) when platelets maintained in Hepes were transferred to a CO2/HCO3- buffer. After an intracellular acidosis induced by an NH4Cl prepulse, the initial velocity of recovery (d(pH)/dt(i), in pH units/min) was 3.32 +/- 0.69 in Hepes-buffered solution and 2.85 +/- 0.88 in HCO3- media. Taking into account the differences in buffer capacity, the efflux of acid equivalents after 1.2 min was twice as much in the presence of bicarbonate. The addition of 30 mumol/1 EIPA effectively blocked acid efflux (d(pH)/dt(i) = 0.08 +/ 0.04) in a nominally HCO3- free solution, whereas the recovery was reduced but not abolished (d(pH)/dt(i) = 0.37 +/- 0.10, P < 0.05) in the presence of bicarbonate. The stilbene derivative SITS further inhibited the EIPA-resistant pH(i) recovery. Removal of external Na+ inhibited the HCO(3-)-dependent recovery whereas depletion of internal Cl-, did not suppress it. Depolarization of the membrane had no effect on this recovery. The results suggest the contribution of an electroneutral Na+/HCO3- cotransport in the recovery of pH(i) following an acid load. Both the Na+/H+ antiport and the HCO(3-)-dependent mechanism contribute approx. 50% each to the total acid equivalent efflux during the recovery from a pH(i) 6.46 +/- 0.14 to the basal pH(i) in human platelets.
authors.affiliation: Centro de Investigaciones Cardiovasculares, Facultad de Ciencias Médicas, Universidad Nacional de La Plata, Argentina.
authors.forename: O A
authors.initials: OA
authors.lastname: Gende
authors.forename: H E
authors.initials: HE
authors.lastname: Cingolani
mesh_terms: D012856:4-Acetamido-4'-isothiocyanatostilbene-2,2'-disulfonic Acid / Q000494:pharmacology; D000584:Amiloride / Q000031:analogs & derivatives / Q000494:pharmacology; D001639:Bicarbonates / Q000097:blood*; D001692:Biological Transport / Q000187:drug effects; D001792:Blood Platelets / Q000378:metabolism*; D002352:Carrier Proteins / Q000097:blood*; D002712:Chlorides / Q000494:pharmacology; D006801:Humans; D006863:Hydrogen-Ion Concentration; D011188:Potassium / Q000494:pharmacology; D012964:Sodium / Q000097:blood*; D027982:Sodium-Bicarbonate Symporters
chemical_list: D001639:Bicarbonates; D002352:Carrier Proteins; D002712:Chlorides; D027982:Sodium-Bicarbonate Symporters; D012856:4-Acetamido-4'-isothiocyanatostilbene-2,2'-disulfonic Acid; D000584:Amiloride; D012964:Sodium; D011188:Potassium; C039614:ethylisopropylamiloride